Research guide for for men — mechanisms, protocols, and independent analysis from Compound Review.
Why TB-500 Is Particularly Relevant for Active Men
TB-500 (Thymosin Beta-4 fragment Ac-LKKTETQ) is a 7-amino acid synthetic peptide that promotes tissue repair through actin regulation, angiogenesis, and anti-inflammatory signaling. For men, the primary use cases are musculoskeletal injury recovery — particularly tendon, ligament, and muscle tears common in resistance training and contact sports. TB-500 also shows cardiac protective effects in preclinical models, relevant to men with cardiovascular risk.
TB-500 Dosage Protocol for Men
Standard research protocols for men use 2–2.5 mg subcutaneously twice weekly for 4–6 weeks as a loading phase, then 2–2.5 mg every 2 weeks for maintenance. TB-500 is frequently stacked with BPC-157 (200–500 mcg daily) for complementary connective tissue repair — BPC-157 targets the NO/VEGF pathway while TB-500 targets the actin/cell migration pathway. This combination is among the most commonly reported in injury recovery research.
Evidence Summary by Application
TB-500 has no known androgenic activity and does not interact with the HPG axis. It does not suppress endogenous hormone production. Evidence is preclinical; no human RCTs have been completed. The compound is not FDA-approved. WADA prohibits it under the S2 Peptide Hormones category.